Orthobiologics Market to Reach US$ 8261.6 Mn by 2026, Growing Patient Awareness Drives Market | Fortune Business Insights

The global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The Global Orthobiologics Market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Orthobiologics Market is likely to gain traction on account of rising geriatric population, which in turn is indicative of the increasing prevalence of chronic arthritis. Fortune Business Insights published a report, titled “Orthobiologics Market Size, Share and Global Trend by Product Type (Viscosupplements, Bone Growth Stimulators, Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cells, Allografts), Application (Spinal Fusion, Maxillofacial & Dental, Soft Tissue Repair, Reconstructive & Fracture Surgery), End User (Hospitals, Ambulatory Surgical Centers, Speciality Clinics) and Geography Forecast till 2025” which offers valuable insights into the drivers positively impacting the global market.

As per this report, the global market for orthobiologics was valued at US$ 5830.1 Mn in the year 2018 and is anticipated to reach US$ 8261.6 Mn by the end of 2026. The global orthobiologics market is projected to exhibit a CAGR of 4.5% throughout the forecast period.

Request Sample Copy at https://www.fortunebusinessinsights.com/enquiry/sample/orthobiologics-marke-100173

Demand for Spinal Fusion Method Expected to Increase

A lead analyst at Fortune Business Insights said, “Spinal fusion covered the highest share in the global orthobiologics market in 2018 owing to the rising prevalence of traumatic injuries and accidents.” “The advantages offered by orthobiologics regarding the treatment of spine-related injuries may fuel the demand for spinal fusion method,” he continued. Another application called soft tissue repair is anticipated to witness the highest growth on account of escalating demand for orthobiologics in cartilage repair. Rising incidence of sports injuries is also responsible for driving the soft tissue repair segment.

Favorable Reimbursement Policies Supports Growth in North America

From a geographical standpoint, North America is expected to lead the global orthobiologics market between 2028 and 2026. In 2018, the market for orthobiologics in North America has valued at US$ 2326.2 Mn. Favourable reimbursement policies in the U.S. and rising adoption of advanced orthobiologics therapies are key factors contributing to the market’s growth in the region. The rising demand for a better quality healthcare in North America is also expected to create growth opportunities for the orthobiologics market in the region. Trailing North America, Europe is the second most prominent region, covering a significant share in the global market for orthobiologics. Growth of the orthobiologics market in Europe is attributable to recent FDA approvals for orthobiologics products. The rising demand for viscosupplements and increasing number of orthopaedic clinics are factors driving the orthobiologics market in Asia Pacific.

BioFiber by Tornier and Similar Product Developments to Boost Growth

The global orthobiologics market is driven by emerging technologies in orthobiologics treatment. For instance, a technology called 3D printed implant offers better stability and significantly reduces surgery time. A global leader in orthopaedics called Tornier has launched BioFiber Surgical Mesh. This technology helps to repair ligament injuries and other muscle injuries. Growing geriatric population is another factor fuelling demand for orthobiologics products such as orthobiologics injections. The rising clearances for several orthobiologics products is driving the orthobiologics market during the forecast period. Other factors likely to boost the orthobiologics market include increasing demand for advanced treatment and high growth potential especially in emerging countries.

Stringent Regulations and High Cost May Restrict the Market to Grow

Although the orthobiologics market is growing considerably, there are some factors that may hamper the growth. These include high costs associated with orthobiologics treatment. People in low-income regions cannot afford such treatments and this may pose a serious threat to the growth of the orthobiologics market. Another factor hampering the market is strict approval process for orthobiologics treatment and products.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/orthobiologics-marke-100173

NuVasive’s Launch of Propel DBM in 2018, to Boost its Market Position

Some of the leading players presently operating in the global orthobiologics market are Medtronic, Stryker, Sanofi, Zimmer Biomet, Bioventus, Sea Spine, Musculoskeletal Transplant Foundation, Wright Medical Group N.V., and RTI Surgical Holdings, Inc. Companies are focussing on launching new and technologically advanced orthobiologic products to increase their share in the orthobiologics market. For instance, NuVasive announced the launch of a new product called Propel DBM in 2018. This product helps to encourage bone growth among patients suffering from bone disorders.

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India
Phone: +1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/orthobiologics-market-to-reach-us-82616-mn-by-2026-growing-patient-awareness-drives-market-fortune-business-insights/513471

Source: MarketersMedia

Release ID: 513471

More News From Action Swift

Bigger tires in store for Formula One

Jul 23, 2019

NEWPORT, R.I. — Formula One tires are getting a makeover to make them look more like the ones auto racing fans can buy for their own cars. The circuit will switch to 18-inch tires beginning in the 2021 season, one of a series of changes it is making as it embarks on a new contract with the Italian tire-maker Pirelli that begins next year and runs through 2023. F1 has used 13-inch tires for decades. "The change ... is designed to more closely align Formula 1 tires with street tires, allowing an even greater degree of technology transfer between them,"...

The Latest: New mid-engine Corvette starts under $60,000

Jul 23, 2019

WARREN, Mich. — The Latest on the introduction of the new mid-engine Chevrolet Corvette: (all times local): 12:10 a.m. GM President Mark Reuss says the new 2020 version of the Chevrolet Corvette will start under $60,000, 7% more than the current car's base price of $55,900. Prices of other versions weren't announced but the current Corvette can run well over $100,000 with options. That's still thousands cheaper than most European competitors. General Motors unveiled the new car Thursday night at a glitzy ceremony in a World War II dirigible hangar in Orange County, California. Engineers say they moved the V8...

Jerry Seinfeld learns from comedy's best on Netflix series

Jul 23, 2019

BEVERLY HILLS, Calif. — Jerry Seinfeld says he'd rather ride classic cars and sip coffee with comedy's best than reboot his uber-successful "Seinfeld" television series. Seinfeld said in an interview Wednesday night that bringing back his eponymous sitcom that recently celebrated its 30-year anniversary would be "egomaniacal." The comedian says he is focused on learning more about the "sharpest minds in comedy" through his Netflix series "Comedians in Cars Getting Coffee." The 11th season premieres Friday on the streaming service featuring Eddie Murphy. The season also includes other comedians including Jamie Foxx, Martin Short, Rick Gervais, Bridget Everett and more....

VW, Ford team up to make autonomous, electric vehicles

Jul 23, 2019

NEW YORK — Volkswagen will invest $2.6 billion into a Pittsburgh autonomous vehicle company that's mostly owned by Ford as the automakers who were once rivals deepen their partnership to develop driverless and electric vehicles in an ultra-competitive landscape. The two automakers will become equal owners of Argo AI, and they plan to put autonomous vehicles on the roads in the U.S. and Europe as early as 2021, the companies said Friday. The deal also includes a plan for Ford to use VW's electric vehicle platform to build zero-emissions cars for the European market starting in 2023. Auto companies have...

The Latest: Experts like what they see in Ford, VW tie-up

Jul 23, 2019

NEW YORK — The Latest on Ford's alliance with Volkswagen (all times local): 9:25 a.m. Auto industry watchers say Ford and Volkswagen have the right idea with their new partnership to develop autonomous and electronic vehicle technology. The companies on Friday announced Friday that Volkswagen will invest $2.6 billion into a Pittsburgh autonomous vehicle company that's mostly owned by Ford. Jessica Caldwell, executive director industry insights for the Edmunds.com auto pricing site, says the deal should help both companies and is an example of what's needed in the business to share enormous capital costs. She says both automakers are facing...

Sign up now!

Action Swift is your fighting sports news site featuring boxing, fencing, martial arts, mixed martial arts and sumo. It’s time for some action!

Contact us: sales[at]actionswift.com